February 2025's Top US Penny Stocks To Watch

As the S&P 500 hovers near record highs and treasury yields drop following retail sales data, investors are keeping a close eye on the broader U.S. market trends. Penny stocks, often associated with smaller or newer companies, remain an intriguing investment area despite their vintage name. These stocks can offer a blend of affordability and growth potential when backed by solid fundamentals, making them worth considering for those seeking opportunities in this unique segment of the market.

Top 10 Penny Stocks In The United States
Name Share Price Market Cap Financial Health Rating
BAB (OTCPK:BABB) $0.8964 $6.3M ★★★★★★
QuantaSing Group (NasdaqGM:QSG) $3.08 $131.87M ★★★★★★
BTCS (NasdaqCM:BTCS) $2.81 $46.67M ★★★★★★
Imperial Petroleum (NasdaqCM:IMPP) $2.84 $86.14M ★★★★★★
Permianville Royalty Trust (NYSE:PVL) $1.395 $46.2M ★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U) $4.50 $67.38M ★★★★★★
CBAK Energy Technology (NasdaqCM:CBAT) $0.8977 $80.89M ★★★★★☆
Smith Micro Software (NasdaqCM:SMSI) $1.40 $24.65M ★★★★★☆
PHX Minerals (NYSE:PHX) $4.17 $154.8M ★★★★★☆
Safe Bulkers (NYSE:SB) $3.61 $382.26M ★★★★☆☆

Click here to see the full list of 710 stocks from our US Penny Stocks screener.

Here's a peek at a few of the choices from the screener.
Edesa Biotech (NasdaqCM:EDSA)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on the research, development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases, with a market cap of $6.45 million.
Operations: Currently, there are no reported revenue segments for this clinical-stage biopharmaceutical company.
Market Cap: $6.45M
Edesa Biotech, Inc., a pre-revenue clinical-stage biopharmaceutical company with a market cap of US$6.45 million, recently raised US$14.99 million through private placements to bolster its financial runway amid concerns over its ability to continue as a going concern. Despite being debt-free and having an experienced management team, the company faces challenges such as high share price volatility and insufficient short-term asset coverage for liabilities. With earnings forecasted to decline by 6.5% annually over the next three years and no significant revenue streams, Edesa remains unprofitable with limited cash runway extension prospects without further capital raising efforts.

Take a closer look at Edesa Biotech's potential here in our financial health report.
Learn about Edesa Biotech's future growth trajectory here.

NasdaqCM:EDSA Financial Position Analysis as at Feb 2025
Cerus (NasdaqGM:CERS)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Cerus Corporation is a biomedical products company with a market cap of $319.43 million.
Operations: The company generates revenue primarily from its Blood Safety segment, which totaled $176.23 million.
Market Cap: $319.43M
Cerus Corporation, with a market cap of US$319.43 million, is focused on its Blood Safety segment, generating US$176.23 million in revenue. Despite being unprofitable, the company has reduced losses by 17.6% annually over five years and maintains a satisfactory net debt to equity ratio of 14.4%. Recent guidance suggests revenue growth with expectations for full-year 2025 product revenue between US$194 million and US$200 million. The company's short-term assets exceed both short- and long-term liabilities, providing financial stability while an experienced management team supports strategic direction amidst executive board changes.

Dive into the specifics of Cerus here with our thorough balance sheet health report.
Explore Cerus' analyst forecasts in our growth report.

NasdaqGM:CERS Debt to Equity History and Analysis as at Feb 2025

Forge Global Holdings (NYSE:FRGE)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Forge Global Holdings, Inc. operates a financial services platform in California and has a market cap of approximately $149.73 million.
Operations: The company generates revenue primarily from its Integrated Private Markets Service Provider segment, which accounted for $79.80 million.
Market Cap: $149.73M
Forge Global Holdings, Inc., with a market cap of approximately US$149.73 million, faces challenges as it remains unprofitable and its losses have increased by a significant rate over the past five years. Despite this, Forge has no debt and maintains sufficient short-term assets to cover liabilities. The company recently appointed James Nevin from LSEG as CFO to enhance financial oversight amid efforts to regain NYSE compliance following a delisting notice due to low share prices. Revenue is expected to grow annually by 25.79%, though profitability is not anticipated in the near term.

Click here to discover the nuances of Forge Global Holdings with our detailed analytical financial health report.
Review our growth performance report to gain insights into Forge Global Holdings' future.

NYSE:FRGE Financial Position Analysis as at

Penny stocks refer to stocks which trade at $5 per share or less. Their market cap is usually micro — under $300 million in total stock equity. That’s the official definition at least. In spirit, these low-priced stocks are volatile and sketchy. They sell hope like other companies sell products. Despite it all, penny stocks are still the best way to build a small account quickly.

Table of Contents
1 3 Penny Stocks to Watch in October 2024
2 Top 3 Penny Stocks to Watch for October 2024
3 Best Penny Stocks for October 2024
3.1 Applied Digital Corp (NASDAQ: APLD) — The Data Center Penny Stock With the NVDA Deal
3.2 POET Technologies Inc. (NASDAQ: POET) — The Optical AI Penny Stock Partnering With Mitsubishi
3.3 Laser Photonics Corporation (NASDAQ: LASE) — The AI-Enabled Laser Penny Stock
4 Top Stocks Under $5
5 How to Use This Penny Stocks Watch List
6 Can You Trade Penny Stocks?
7 What Are the Advantages of Investing in Penny Stocks?
7.1 You Can Buy Many Shares at a Low Price
7.2 You Can Start Trading with a Small Account
7.3 Easy to See Gains
7.4 Competition is Low
7.5 Possible Price Growth
8 Potential Risks of Investing in Penny Stocks
8.1 High Volatility
8.2 Low Liquidity
8.3 Pump-and-Dump Scams
8.4 Lack of Information
9 5 Tips on How to Choose the Best Penny Stocks to Watch
9.1 Tip #1: Look for Big Percent Gainers
9.2 Tip #2: Look for Big Volume
9.3 Tip #3: Look for a Penny Stock News Catalyst
9.4 Tip #4: Look at the Long-Term Charts
9.5 Tip #5: Use the Twitter Scanner on StocksToTrade
10 If Most Penny Stock Companies Fail, Why Not Just Short Sell?
11 How Much Money Do I Need to Get Started?
11.1 How Do You Become a Millionaire Trader?
12 Join My Trading Challenge Today
13 Conclusion
14 FAQs
14.1 What Are Penny Stocks?
14.2 Are Penny Stocks Worth It?
14.3 Are Penny Stocks Dangerous?
14.4 How Do You Watch Penny Stocks?
14.5 Can You Become a Millionaire from Penny Stocks?
14.6 How Often Do Penny Stocks Go Big?
14.7 What Have Been the Most Successful Penny Stocks?
14.8 What Do Analysts Say About Penny Stocks?
14.9 What Markets Are Most Common for Penny Stocks?
14.10 How Can I Stay Updated on Penny Stocks?